https://www.solascure.com/news/solascure-completes-phase-ii-clinical-trial-demonstrating-accelerated-healing-with-aurase-wound-gel 2026-02-25 https://www.solascure.com/news/wound-care-voices-the-unfolding-revolution-in-wound-care 2025-10-17 https://www.solascure.com/news/biocap-2025-pitches---solascure 2025-10-15 https://www.solascure.com/news/wound-care-voices-why-investors-should-rethink-wound-care 2025-09-17 https://www.solascure.com/news/solascure-publishes-dose-escalation-study-on-painless-application-of-aurase-wound-gel 2025-07-21 https://www.solascure.com/news/the-silent-suffering-chronic-pain-in-chronic-wounds 2025-06-25 https://www.solascure.com/news/the-potential-role-for-a-painless-enzymatic-debridement-gel-in-wound-bed-preparation-for-venous-leg-ulcers%E2%80%94a-dose-escalation-study 2025-06-16 https://www.solascure.com/news/enzyme-based-debridement%3A-revolutionising-chronic-wound-healing 2025-06-16 https://www.solascure.com/news/solascure-receives-fda-fast-track-designation-for-aurase-wound-gel-to-treat-calciphylaxis-ulcers 2025-06-16 https://www.solascure.com/news/wound-care-voices-driving-the-shift-from-wound-care-to-wound-therapy-and-healing 2025-05-30 https://www.solascure.com/news/new-modalities%3A-industry-predictions-for-2025 2025-04-24 https://www.solascure.com/news/solascure-enrols-first-patient-in-a-next-phase-ii-clinical-trial-to-advance-aurase-wound-gel 2025-03-17 https://www.solascure.com/news/wound-care-voices%3A-why-enzymes-are-just-what-wound-care-clinicians-have-been-looking-for 2024-12-13 https://www.solascure.com/news/solascure-and-us-army-institute-of-surgical-research-collaborate-for-combat-wound-care 2025-09-17 https://www.solascure.com/news/wound-care-voices-why-the-battle-against-chronic-wounds-is-worth-fighting 2025-04-24 https://www.solascure.com/news/solascure-publishes-phase-iia-clinical-trial-report-in-leading-wound-care-journal 2024-10-02 https://www.solascure.com/news/brain-biotech-ag-announces-the-creation-of-solascure-ltd.-to-continue-development-of-aurase 2024-09-27 https://www.solascure.com/news/startup-solascure-chosen-for-the-urgo-mentorship-program 2024-09-27 https://www.solascure.com/news/will-chronic-wounds-have-a-better-treatment%3F-solascure%2C-a-new-company-in-hovione-capital%E2%80%99s-portfolio. 2024-09-27 https://www.solascure.com/news/a-truly-revolting-treatment-is-having-a-renaissance 2024-09-27 https://www.solascure.com/news/6-ireland-uk-start-ups-ready-for-the-catapult-semifinals 2024-09-27 https://www.solascure.com/news/the-biomimicry-institute's-asknature%3A-improved-wound-debridement-using-maggot-enzymes 2024-09-27 https://www.solascure.com/news/seneca-partners-invests-%C2%A31.2m-into-biotech-start-up-solascure 2024-09-27 https://www.solascure.com/news/solascure-raises-%E2%82%AC12m-in-series-b-finance 2024-09-27 https://www.solascure.com/news/eit-health-catapult-2022-names-solascure-biotech-winner 2024-09-27 https://www.solascure.com/news/european-innovation-council-accelerator%3A-strong-performance-of-engineering-and-tech-based-companies-in-the-latest-%E2%82%AC350-million-funding-round 2024-09-27 https://www.solascure.com/news/treating-chronic-wounds-effectively%3A-the-unmet-need 2024-10-03 https://www.solascure.com/news/harnessing-the-power-of-maggots%3A-cambridge-biologics-company-solascure-is-developing-an-accessible-method-for-cleaning-chronic-wounds%2C-inspired-by-nature%E2%80%99s-solution 2024-10-03 https://www.solascure.com/news/solascure-announces-%C2%A315m-series-a-raise 2024-10-03 https://www.solascure.com/news/biotech-start-up-solascure-has-begun-clinical-trials-of-its-investigational-wound-cleaning-product%2C-aurase-wound-gel 2024-10-03 https://www.solascure.com/news/cambridge-biotech-company-earns-international-recognition-as-first-trial-patient-receives-treatment 2024-10-03 https://www.solascure.com/news/solascure-wins-1st-place-at-prestigious-eit-health-catapult-biotech-competition-for-investigational-wound-care-product-aurase-wound-gel 2024-10-03 https://www.solascure.com/news/solascure%E2%80%99s-david-fairlamb-recognised-at-topra-awards-for-exceptional-leadership-in-regulatory-strategy 2024-10-02 https://www.solascure.com/news/solascure-announces-publication-of-toxicology-and-pre-clinical-research-programme-as-final-patient-is-enrolled-into-pivotal-clinical-trial 2024-10-02 https://www.solascure.com/news/solascure-named-a-uk-life-sciences-innovator-2023-by-the-uk%E2%80%99s-department-for-international-trade 2024-10-02 https://www.solascure.com/news/solascure-announces-final-closing-of-gbp-10.9m-(c.-usd-13.3m)-series-b-fundraise-to-advance-wound-care-innovation 2024-11-05 https://www.solascure.com/news/solascure-awarded-prestigious-european-innovation-council%E2%80%99s-accelerator-grant 2024-10-02 https://www.solascure.com/news/solascure-demonstrates-proof-of-concept-in-phase-lla-safety-trial-of-aurase-wound-gel 2024-10-02 https://www.solascure.com/news/wound-bed-preparation%3A-addressing-the-urgent-need-for-effective-solutions 2024-10-02 https://www.solascure.com/news/solascure-selected-for-innovate-uk-global-incubator-programme-in-houston 2024-11-14 https://www.solascure.com/news/solascure-awarded-%C2%A3405k-innovate-uk-biomedical-catalyst-grant-to-advance-chronic-wound-care 2024-11-05 https://www.solascure.com/news/first-clinical-evaluation-of-the-safety-and-efficacy-of-tarumase-for-the-debridement-of-venous-leg-ulcers 2024-09-27 https://www.solascure.com/news/preliminary-evidence-supporting-a-new-enzymatic-debridement-product-for-use-in-chronic-wounds 2024-09-27